This announcement is a separate document:
寿仙谷：浙江寿仙谷医药股份有限公司和国信证券股份有限公司关于《关于请做好浙江寿仙谷医药股份有限公司公开发行可转债发审委会议准备工作的函》的回复
Shouxiangu: Response from Zhejiang Shouxiangu Pharmaceutical Co., Ltd. and Guoxin Securities Co., Ltd. to the “Letter on Please Complete Preparation for the Development and Review Committee Meeting on the Public Issuance of Convertible Bonds by Zhejiang Sh
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated